CD4 c.951G>A ;(p.M317I)

Variant ID: 12-6925565-G-A

NM_000616.4(CD4):c.951G>A;(p.M317I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: CD4: M317I
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
View BVdb publication page



Susceptibility of HIV-1 subtypes B', CRF07_BC and CRF01_AE that are predominantly circulating in China to HIV-1 entry inhibitors.

Plos One
Yu, Xiaoling X; Yuan, Lin L; Huang, Yang Y; Xu, Weisi W; Fang, Zhiming Z; Liu, Shuwen S; Shao, Yiming Y; Jiang, Shibo S; Ma, Liying L
Publication Date: 2011-03-11

Variant appearance in text: CD4: M317I
PubMed Link: 21412427
Variant Present in the following documents:
  • Main text
  • pone.0017605.pdf
View BVdb publication page